Clinical Trials Browser

Phase 2 × Esophageal Squamous Cell Carcinoma × Endostatins × Clear all

NCT02350517 2023-02-16

Endostar Combined With Paclitaxel and Nedaplatin in Treating Patients With Recurrent or Metastatic Esophageal Cancer

Phase 2 Completed

Gastrointestinal

Esophageal Squamous Cell Carcinoma